Head of organization representing many of state’s largest life science companies fears research could be crippled
By BINJE Staff, January 16, 2026
HealthCare Institute of New Jersey CEO Chrissy Buteas is skeptical of some of the provisions in the “Great Healthcare Plan” released Thursday by the Trump administration.
Among other items in a plan that was big on outcomes but light on how they will be achieved, were potential policies aimed at price controls.
Buteas said an unintended consequence would be limiting research.
“Today’s proposal of mandatory price controls would cripple our ability to find those new treatments and cures,” she said. Read the full article here.